Waldenstrom macroglobulinemia is a rare type of non-Hodgkin lymphoma characterized by the overproduction of IgM antibodies by abnormal B cells. In remission, the disease shows no active symptoms or signs, which is clinically significant for patient management and treatment planning. The ICD-10 Code C88.01 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this condition.
ICD-10 Code C88.01 specifically denotes Waldenstrom macroglobulinemia that is currently in remission. This condition involves the presence of monoclonal IgM paraprotein and is associated with various clinical manifestations. This code should be used when documenting patients who have achieved remission, indicating the absence of active disease, which is crucial for accurate billing and clinical management.
Waldenstrom macroglobulinemia, in remission, occurs when the disease is controlled, and patients exhibit no significant symptoms. This condition arises from the proliferation of lymphoplasmacytic cells, leading to high levels of IgM. Regular monitoring is essential to ensure the disease remains in remission and to manage any potential complications.
ICD-10 Code C88.01 is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. This code is relevant in both acute and chronic care settings, ensuring that healthcare providers can accurately track the patient's condition and response to treatment.
In SOAP notes, ICD-10 Code C88.01 connects subjective patient reports and objective clinical findings to a formal diagnosis of Waldenstrom macroglobulinemia in remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Waldenstrom macroglobulinemia in remission focuses on monitoring and supportive care. While antibiotic therapy is not typically required, vigilance for potential infections is essential.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C88.01 is essential for accurate billing in hospital, ER, or outpatient settings, particularly for patients in remission.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, low complexity |
| 36415 | Collection of venous blood by venipuncture |
| 85025 | Complete blood count with differential |
Common Questions About Using ICD-10 Code C88.01 for Waldenstrom macroglobulinemia, in remission
What does it mean for Waldenstrom macroglobulinemia to be in remission?
Remission in Waldenstrom macroglobulinemia indicates that the disease is not currently active, and the patient is not experiencing significant symptoms. Regular monitoring is essential to ensure that the disease remains controlled.
How is Waldenstrom macroglobulinemia treated?
Treatment for Waldenstrom macroglobulinemia may include chemotherapy, targeted therapy, or immunotherapy, depending on the patient's specific condition and response to treatment. In remission, the focus shifts to monitoring.
When should ICD-10 Code C88.01 be used?
ICD-10 Code C88.01 should be used when documenting patients with Waldenstrom macroglobulinemia who are currently in remission, indicating no active disease.
What are the common symptoms of Waldenstrom macroglobulinemia?
Common symptoms include fatigue, weight loss, night sweats, and bleeding tendencies. In remission, these symptoms should be absent or significantly reduced.
Clinical Notes
SOAP notes
DAP notes
AI medical notes